rs116840750
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_000168.6(GLI3):c.2146C>T(p.Gln716*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
NM_000168.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
GLI3-related disorder Pathogenic:1
The GLI3 c.2146C>T variant is predicted to result in premature protein termination (p.Gln716*). This variant was reported in an individual with Pallister-Hall syndrome (Table 1, Johnston et al. 2005. PubMed ID: 15739154). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in GLI3 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at